| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 03/08/2006 | CN1745071A Novel ethylenediamine derivatives |
| 03/08/2006 | CN1744895A N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/07/2006 | US7008956 p53 inhibitors and therapeutic use of the same |
| 03/07/2006 | US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors |
| 03/02/2006 | WO2006021213A2 Vasopressin v1a antagonists |
| 03/02/2006 | WO2005123672A3 Kinase inhibitors |
| 03/02/2006 | WO2005092895A3 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists |
| 03/02/2006 | WO2005092858A3 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist |
| 03/02/2006 | DE102004041163A1 Neue Verbindungen mit antibakterieller Aktivität New compounds with antibacterial activity |
| 03/02/2006 | CA2689274A1 Vasopressin via antagonists |
| 03/02/2006 | CA2688912A1 Vasopressin v1a antagonists |
| 03/02/2006 | CA2688865A1 Vasopressin v1a antagonists |
| 03/01/2006 | EP1630159A1 5-HT7 receptor antagonists |
| 03/01/2006 | EP1630158A1 5-HT7 receptor antagonists |
| 03/01/2006 | EP1628981A2 Bicyclicpyrimidones and their use to treat diseases |
| 03/01/2006 | EP1628967A1 Immunosuppressant compounds and compositions |
| 03/01/2006 | CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors |
| 03/01/2006 | CN1740179A N4-substituent pyrazolyl [4,5-e][1,2,4] thiadiazine derivative and its prepn process and medicine composition |
| 03/01/2006 | CN1243756C Process and ester derivatives for preparing cephalosporins |
| 02/28/2006 | CA2173116C Ring-expanded nucleosides and nucleotides |
| 02/23/2006 | WO2006020082A1 Inhibitors of hcv replication |
| 02/23/2006 | WO2006018309A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2006018308A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
| 02/23/2006 | US20060041123 Antibacterial agents |
| 02/23/2006 | US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 02/23/2006 | US20060040934 Use of STAT-6 inhibitors as therapeutic agents |
| 02/23/2006 | US20060040928 amyloid precursor protein and gamma -secretase inhibitor; 3,4,6,7,8,9-Hexahydro-2-methyl-3-oxo-2H-naphtho[2,3-e]-1,2-thiazine-4-carboxanilide 1,1-dioxide; neurodegenerative disease: Alzheimer's disease, amyloid plaque, Parkinson's disease, Down's syndrome, hemorrhage, arteriosclerosis |
| 02/23/2006 | US20060040925 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/23/2006 | CA2576421A1 Inhibitors of hcv replication |
| 02/23/2006 | CA2575785A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575771A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575188A1 Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer |
| 02/23/2006 | CA2575056A1 Selected fused heterocyclics and uses thereof |
| 02/22/2006 | EP1626975A2 PROCESS FOR SYNTHESIZING ß-LACTAMASE INHIBITOR IN INTERMEDIATES |
| 02/22/2006 | EP1441735B1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/22/2006 | CN1738825A Thienopyridazinones and their use in modulation of autoimmune disease |
| 02/22/2006 | CN1738615A Diaminotriazoles useful as inhibitors of protein kinases |
| 02/21/2006 | US7001914 Compounds |
| 02/16/2006 | WO2005097107A8 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 02/16/2006 | CA2576581A1 Substituted indole compounds, their preparation and use in medicaments |
| 02/15/2006 | EP1626051A1 Crystals of quinolinecarboxylic acid derivative solvate |
| 02/15/2006 | EP1626050A1 Sulfur-containing naphthoylimide derivatives |
| 02/15/2006 | EP1625126A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 02/15/2006 | EP1625121A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/15/2006 | CN1735612A Anti-infective agents |
| 02/09/2006 | WO2005097089A3 Derivatives of leinamycin for use as anticancer agents |
| 02/09/2006 | CA2575100A1 Heterocyclic compounds |
| 02/08/2006 | EP1622685A1 9-azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors |
| 02/08/2006 | EP0988045B1 Peptide nucleic acid monomers and oligomers |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | CA2573538A1 Inhibitors of vegf receptor and hgf receptor signaling |
| 02/01/2006 | EP1620441A1 Thiadiazine derivatives and use thereof as positive ampa receptor modulators |
| 02/01/2006 | EP1620440A1 Synthesis of substituted heterocyclic compounds |
| 02/01/2006 | EP1620438A1 Tricyclic indole derivatives and their use in the treatment of alzheimer's disease |
| 02/01/2006 | EP1620088A2 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 02/01/2006 | CN1729197A Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 02/01/2006 | CN1729178A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 02/01/2006 | CN1728999A Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/01/2006 | CN1727348A Derivant of cephalosporin alkene, and preparation method |
| 01/31/2006 | US6992102 Bicyclic modulators of androgen receptor function |
| 01/31/2006 | CA2224635C Pyridine derivatives, process for preparing the same, and intermediate therefor |
| 01/26/2006 | WO2006008556A1 Imidazole and thiazole derivatives as antiviral agents |
| 01/26/2006 | WO2005092304A3 Antifungal agents |
| 01/26/2006 | WO2005085234A3 Bycyclic anthranilamide derivatives useful as insecticides |
| 01/26/2006 | US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases |
| 01/26/2006 | CA2574354A1 Imidazole and thiazole derivatives as antiviral agents |
| 01/26/2006 | CA2574204A1 Fused pyrimidones useful in the treatment and the prevention of cancer |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1618115A1 Industrial process for preparing environmentally safe tricyclazole |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | CN1238348C Oxazin(thio)one compounds used as fungicides |
| 01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989379 Selective NPY (Y5) antagonists |
| 01/24/2006 | CA2123093C Sulfonamide herbicides |
| 01/19/2006 | WO2005117890A3 Thienopyrimidines and thiazolopyrimidines for use in medicine |
| 01/19/2006 | WO2005105805A9 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof |
| 01/19/2006 | US20060014749 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 01/19/2006 | US20060014746 Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 01/19/2006 | CA2581674A1 Indoleamine 2,3-dioxygenase (ido) inhibitors |
| 01/18/2006 | EP1615886A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1615878A2 Compounds, compositions and methods |
| 01/18/2006 | EP1615639A2 Targeted bone marrow protection agents |
| 01/18/2006 | EP1207161B1 Novel isoindole derivatives |
| 01/18/2006 | EP0954308B1 Therapeutic treatment for cardiovascular diseases |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/17/2006 | CA2152284C Condensed benzo(d)isoxazole derivatives and their use as psychoactive agents |
| 01/12/2006 | WO2006002928A1 Compounds having affinity for the dopamine d3 receptor and uses thereof in medicine |
| 01/12/2006 | US20060009448 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]thiomorpholin-3-one |
| 01/11/2006 | EP1613368A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 01/10/2006 | US6984656 Core modified porphyrins |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/05/2006 | WO2005035505A3 Compounds with phosphodiesterase inhibiting and calcium channel blocking activities |
| 01/05/2006 | WO2004091504A3 Substituted quinobenzoxazine analogs |
| 01/05/2006 | US20060004009 Ethylenediamine derivatives |
| 01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610759A2 Substituted quinobenzoxazine analogs |